Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19
Clinical Results: STEP and SURMOUNT Trials GLP-1 medications are backed by some of the largest clinical trials in obesity medicine history
The most famous GLP-1 agonist, semaglutide, was developed by the Danish company Novo Nordisk
Recommended Timing Protocols Morning Fasted Protocol (Most Common): Timing: Upon waking, before any food or caloric beverages Fasting Window: At least 8-10 hours fasted from overnight sleep Post-Injection: Wait 30-60 minutes before eating breakfast Activity: Light fasted cardio or morning routine before first meal may enhance fat mobilization Advantages: Convenient, consistent daily routine, maximizes overnight fasted state Pre-Exercise Protocol: Timing: 30-45 minutes before fasted cardio or training session Fasting Window: At least 4-6 hours since last meal Rationale: Exercise during fasted state with elevated free fatty acids may enhance fat oxidation Considerations: Not suitable for high-intensity training
Microb Pathog
)
